# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential...
Needham analyst Serge Belanger downgrades DICE Therapeutics (NASDAQ:DICE) from Buy to Hold.
Canaccord Genuity analyst Edward Nash downgrades DICE Therapeutics (NASDAQ:DICE) from Buy to Hold and lowers the price targe...
HC Wainwright & Co. analyst Emily Bodnar downgrades DICE Therapeutics (NASDAQ:DICE) from Buy to Neutral and announces $4...